Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
about
Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized studyComparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus.Recommendations for monitoring serum vancomycin concentrationsDaptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.Prophylactic antibiotic administration for post cardiothoracic surgery sternal wounds: a retrospective studyPrediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection.Traditional weight-based vancomycin dosing is inadequate in critically ill trauma patients.Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusPotential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Medication-related complications in the trauma patient.Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaUnderestimation of the calculated area under the concentration-time curve based on serum creatinine for vancomycin dosing.Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients.Evaluation of a Pharmacist-Directed Vancomycin Dosing and Monitoring Pilot Program at a Tertiary Academic Medical Center.Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.Dehydroepiandosterone induction of increased resistance to vancomycin in Staphylococcus aureus clinical isolates (MSSA, MRSA).Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
P2860
Q33304458-9D93FD71-E02A-4356-BDBC-5209239CC2A5Q33982863-3CF78DA3-C1FE-49E9-B9E5-85A4A2423393Q34150985-37478FFE-60D3-4FAB-9B56-356E73CF0A5BQ34151183-FDA42069-BFE3-4CEA-9C1D-DF801391FFEDQ34718540-0257B34C-E678-49A8-9394-DDDE5A630D9FQ35238093-5CD07197-4505-4CE7-9877-2F0F7C2236EBQ35270746-B2FDD134-41A0-403F-AEEA-E175AB71FB4AQ35835173-7F4526AE-E1BC-43F0-BD57-E052B72A032AQ35905703-9319658B-9C6D-4E8E-AF52-329B405F7DFDQ36095086-2913AC7C-F487-43BC-A2DF-5BACCE6B69CFQ36428418-484E1AEF-2278-4C58-B3C8-4AF8B1144738Q36505518-08164E62-D111-4EAC-9E85-CEA24F4FBD7FQ36735202-52BD10C8-4FAF-4E78-ADA7-DD4CE9EC3C31Q36847287-19DCBA40-5842-4BEE-A085-C26589EB5A6CQ37121344-35407153-ACEF-4984-82D2-97364161ABE5Q37220711-F33F9CDF-280F-4558-8AAA-305E7849FA9FQ37673492-59C1E55C-757B-4BDF-9625-3AD6CF79C809Q38238908-A55D0B02-9350-4EDA-ACF2-169BC66C4B90Q38492826-91411C46-B502-49A0-BF5E-C691EB2BB7C9Q38818376-F0BB38CA-C5EE-4831-965E-32A786DFE1AFQ40481176-B079D588-CFF4-49E7-BC7E-19C4D11B1098Q45307997-0768A727-4D86-4091-A4CE-57C6112F722DQ48089081-9883FCAE-BED8-441C-95EA-AEE8714BDD2FQ51506580-8D64AEB0-5991-4778-84AB-DF78953977E2Q51575000-0EF79D42-EBCB-4516-8C69-7AFA32F4E9AA
P2860
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@ast
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@en
type
label
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@ast
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@en
prefLabel
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@ast
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@en
P2093
P2860
P1433
P1476
Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.
@en
P2093
McKinnon PS
Neuhauser MM
P2860
P304
P356
10.1592/PHCO.19.4.257.30933
P407
P577
1999-03-01T00:00:00Z